A multi-agent system for automating scientific discovery
Top Cited Papers
Open Access
- 19 May 2026
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 655 (8122) , 497-505
Abstract
Scientific discovery is driven by the iterative process of observation, hypothesis generation, experimentation, and data analysis. Despite recent advancements in applying artificial intelligence to biology, no system has yet automated all these stages [1, 2, 3]. Here, we introduce Robin, the first multi-agent system capable of fully automating both hypothesis generation and data analysis for experimental biology. By integrating literature search agents with data analysis agents, Robin can generate hypotheses, propose experiments, interpret experimental results, and generate updated hypotheses, achieving a semi-autonomous approach to scientific discovery. By applying this system, we were able to identify promising therapeutic candidates for dry age-related macular degeneration (dAMD), the major cause of blindness in the developed world [4, 5]. Robin proposed enhancing retinal pigment epithelium phagocytosis as a therapeutic strategy, and identified and confirmed in vitro efficacy for ripasudil and KL001. Ripasudil is a clinically-used Rho kinase (ROCK) inhibitor that has never previously been proposed for treating dAMD. To elucidate the mechanism of ripasudil-induced upregulation of phagocytosis, Robin then proposed and analyzed a follow-up RNA-seq experiment, which revealed upregulation of ABCA1, a lipid efflux pump and possible novel target. All hypotheses, experimental directions, data analyses, and data figures in the main text of this report were produced by Robin. As the first AI system to autonomously discover and validate novel therapeutic candidates within an iterative lab-in-the-loop framework, Robin establishes a new paradigm for AI-driven scientific discovery.Keywords
All Related Versions
This publication has 53 references indexed in Scilit:
- 2024 FDA approvals exceed average number but have lower sales projectionsNature Reviews Drug Discovery, 2025
- Age-Related Macular DegenerationJAMA, 2024
- Biology must generate ideas as well as dataNature, 2021
- Stem Cell–Derived Retinal Pigment Epithelial Layer Model from Adult Human Globes Donated for Corneal TransplantsCurrent Protocols in Stem Cell Biology, 2018
- Quantified F-Actin Morphology Is Predictive of Phagocytic Capacity of Stem Cell-Derived Retinal Pigment EpitheliumStem Cell Reports, 2018
- Evidence of association ofAPOEwith age-related macular degeneration - a pooled analysis of 15 studiesHuman Mutation, 2011
- Forecasting Age-Related Macular Degeneration Through the Year 2050Archives of Ophthalmology (1950), 2009
- Antidepressant effects of ketamine in depressed patientsBiological Psychiatry, 2000
- ARPE-19, A Human Retinal Pigment Epithelial Cell Line with Differentiated PropertiesExperimental Eye Research, 1996
- Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridinesJournal of Medicinal Chemistry, 1992